menu
    • menu

    Company profile for Pendopharm

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PendoPharm Inc a pharmaceutical company, develops, manufactures, markets, and licenses specialty prescription medicinal, BTC, and over-the-counter (OTC) products for medical community and patients in Canada. It offers consumer healthcare and prescription/specialty products primarily in the areas of urology, oncology, gastroenterology, pediatrics, cough and cold, nasal hydration and congestion, and acute care. The company also ...
    PendoPharm Inc a pharmaceutical company, develops, manufactures, markets, and licenses specialty prescription medicinal, BTC, and over-the-counter (OTC) products for medical community and patients in Canada. It offers consumer healthcare and prescription/specialty products primarily in the areas of urology, oncology, gastroenterology, pediatrics, cough and cold, nasal hydration and congestion, and acute care. The company also provides oral ribavirin tablets for the treatment of chronic hepatitis C virus infections; and omeprazole delayed-release tablets for the treatment of heartburn.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PendopharmCanada Flag
    Country
    Country
    Canada
    Address
    Address
    6111 Royalmount Avenue Montreal (Quebec) H4P 2T4
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pendopharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    KalVista & Pendopharm Ink Deal for Sebetralstat in Canada
    KalVista & Pendopharm Ink Deal for Sebetralstat in Canada

    26 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250626645779/en/KalVista-Pharmaceuticals-Enters-into-Licensing-Agreement-with-Pendopharm-to-Commercialize-Sebetralstat-for-HAE-in-Canada

    BUSINESSWIRE
    26 Jun 2025
    Share Share
    Health Canada Issues Recall of Pendopharm Division of Pharmascience's AXID
    Health Canada Issues Recall of Pendopharm Division of Pharmascience's AXID

    04 May 2020

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-pendopharm-division-of-pharmasciences-axid-1588660442.pdf

    HEALTH CANADA
    04 May 2020
    Share Share
    Pendopharm Issues Recall of Olex Tablet Due to The Affected Lots May be Out of Specification For Impurities
    Pendopharm Issues Recall of Olex Tablet Due to The Affected Lots May be Out of Specification For Impurities

    11 Apr 2017

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/pendopharm-issues-recall-of-olex-due-the-affected-lots-may-be-out-of-specification-for-impurities-1491891455.pdf

    HEALTH CANADA
    11 Apr 2017
    Share Share
    Australia bets $1B on pricey hepC drug in broad effort to eradicate the disease
    Australia bets $1B on pricey hepC drug in broad effort to eradicate the disease

    23 Dec 2015

    // Carly Helfand FIERCE PHARMA

    http://www.fiercepharma.com/story/australia-bets-1b-pricey-hep-c-drugs-broad-effort-eradicate-disease/2015-12-23

    Carly Helfand FIERCE PHARMA
    23 Dec 2015
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search